Literature DB >> 24021505

Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

Maura L Furey1, Carlos A Zarate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24021505      PMCID： PMC5014541          DOI： 10.4088/JCP.13ac08584

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  19 in total

1.  Differential effects of scopolamine on neuronal survival in ischemia and glutamate neurotoxicity: relationships to the excessive vulnerability of the dorsoseptal hippocampus.

Authors:  A Rami; F Ausmeir; J Winckler; J Krieglstein
Journal:  J Chem Neuroanat       Date:  1997-08       Impact factor: 3.052

2.  The effects of acute scopolamine in geriatric depression.

Authors:  P A Newhouse; T Sunderland; P N Tariot; H Weingartner; K Thompson; A M Mellow; R M Cohen; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1988-10

3.  Pathophysiology of "cholinoceptor supersensitivity" in affective disorders.

Authors:  S C Dilsaver
Journal:  Biol Psychiatry       Date:  1986-07       Impact factor: 13.382

4.  Cholinergic reversal of manic symptoms.

Authors:  D S Janowsky; M K el-Yousef; J M Davis; B Hubbard; H J Sekerke
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

5.  Acetylcholine and depression.

Authors:  D S Janowsky; M K el-Yousef; J M Davis
Journal:  Psychosom Med       Date:  1974 May-Jun       Impact factor: 4.312

6.  Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

Authors:  Maura L Furey; Ashish Khanna; Elana M Hoffman; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

7.  The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group.

Authors:  J C Gillin; L Sutton; C Ruiz; D Darko; S Golshan; S C Risch; D Janowsky
Journal:  Biol Psychiatry       Date:  1991-07-15       Impact factor: 13.382

8.  No antidepressant effect of biperiden compared with placebo in depression: a double-blind 6-week clinical trial.

Authors:  J C Gillin; J Lauriello; J R Kelsoe; M Rapaport; S Golshan; W M Kenny; L Sutton
Journal:  Psychiatry Res       Date:  1995-09-29       Impact factor: 3.222

Review 9.  Is cholinergic sensitivity a genetic marker for the affective disorders?

Authors:  D S Janowsky; D H Overstreet; J I Nurnberger
Journal:  Am J Med Genet       Date:  1994-12-15

10.  [Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats].

Authors:  Hui-Fen Liu; Wen-Hua Zhou; Xiao-Hu Xie; Jun-Li Cao; Jun Gu; Guo-Dong Yang
Journal:  Sheng Li Xue Bao       Date:  2004-02-25
View more
  4 in total

Review 1.  Spine synapse remodeling in the pathophysiology and treatment of depression.

Authors:  Catharine H Duman; Ronald S Duman
Journal:  Neurosci Lett       Date:  2015-01-09       Impact factor: 3.046

2.  Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray.

Authors:  Hung-Wei Kan; Wei-Hao Peng; Cheng-Chun Wu; Deng-Wu Wang; Ming Tatt Lee; Yung-Kuo Lee; Tian-Huei Chu; Yu-Cheng Ho
Journal:  Psychopharmacology (Berl)       Date:  2022-10-12       Impact factor: 4.415

3.  Comparison of the muscarinic antagonist effects of scopolamine and L-687,306.

Authors:  Gail Winger; Emily M Jutkiewicz; James H Woods
Journal:  Behav Pharmacol       Date:  2020-06       Impact factor: 2.277

4.  Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses.

Authors:  Manoela V Fogaça; Min Wu; Chan Li; Xiao-Yuan Li; Marina R Picciotto; Ronald S Duman
Journal:  Mol Psychiatry       Date:  2020-10-17       Impact factor: 15.992
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.